the chain reaction pandemic flu and the medicines supply chain michael young mpi department of...
TRANSCRIPT
QuickTime™ and a
TIFF (Uncompressed) decompressorare needed to see this picture.
The Chain ReactionPandemic Flu and the Medicines Supply Chain
Michael Young
MPI Department of Health
PDIG Summer Symposium
Thursday 5th June 2008
(with thanks to Health Protection Agency and MICE Associates)
QuickTime™ and a
TIFF (Uncompressed) decompressorare needed to see this picture.
The Brief from PDIG
1. Flu Pandemic Myth or Reality?
2. How will the Supply Chain cope?
3. Key Strategic measures which will affect the whole Supply
Chain?
QuickTime™ and a
TIFF (Uncompressed) decompressorare needed to see this picture.
Section 1 - Myth or reality?Seasonal, avian and pandemic influenza:
Based on presentation given by Dr Nick PhinPandemic Flu OfficeHealth Protection Agency, Centre for Infections23rd January 2008 – Exercise Chain Reaction Briefing
QuickTime™ and aTIFF (Uncompressed) decompressor
are needed to see this picture.
QuickTime™ and a
TIFF (Uncompressed) decompressorare needed to see this picture.
The Influenza Paradigm
• There are known knowns - there are things we know we know.
We also know there are known unknowns, that is to say, there are some things we do not know.
But there are also unknown unknowns – the ones we don’t know we don’t know.
Donald Rumsfeld
QuickTime™ and a
TIFF (Uncompressed) decompressorare needed to see this picture.
Overall clinical attack rate in previous pandemics
0%
5%
10%
15%
20%
25%
30%
35%
40%
45%
1918 NewYork State
1918Manchester
1918Leicester
1918Warrington& Wigan
1957 SELondon
1957 SouthWales
1957Kansas City
1968Kansas City
cli
nic
al
att
ac
k r
ate
(%
)
QuickTime™ and a
TIFF (Uncompressed) decompressorare needed to see this picture.
Pre-requisites for pandemic influenza
‘PAN’ (all) ‘DEMOS’ (people) = an epidemic that affects all people
• New influenza A sub-type: Haemagglutinin (H)unrelated to immediate (pre-pandemic)predecessor.
• Little or no pre-existing population immunity
• Causes significant clinical illness
• Efficient person-to-person spread
QuickTime™ and a
TIFF (Uncompressed) decompressorare needed to see this picture.
Public Health Measures(hygiene; masks; distancing;
infection control, etc.)
Antibiotics
Antivirals
Pre-pandemic vaccine?
Pandemic Specific Vaccine
Defence in layers
QuickTime™ and a
TIFF (Uncompressed) decompressorare needed to see this picture.
Personal Hygiene
• Respiratory hygiene (“sneeze in your sleeve” – USA CDC; “coughs and sneezes spread diseases” UK DH)
• Virus survival on ‘soft furnishings’ (such as sleeves) is relatively short
• Hand washing – evidence in school settings
• Adherence
• As yet, no embedded UK culture outside ‘health’
QuickTime™ and a
TIFF (Uncompressed) decompressorare needed to see this picture.
Pandemic Vaccine
• It may take 4-6 months or longer to produce a vaccine
• Unlikely to be available during early stages of a pandemic
• Not enough for everybody – production capacity
• Benefits of pre-pandemic vaccine?
QuickTime™ and a
TIFF (Uncompressed) decompressorare needed to see this picture.
Likely shape of the first Wave
QuickTime™ and a
TIFF (Uncompressed) decompressorare needed to see this picture.
Lessons learned from the past and the current situation in South East Asia
• maximum recorded interval between pandemics is 39 years – it could be
soon (but it remains unpredictable)
• the likely origin will be SE Asia – but we can’t say for sure
• global spread will be rapid – we either prepare now, or risk being caught
by surprise
• may be several epidemic waves; first may be ‘milder’ than subsequent
ones – sustainability and resilience will be key issues
• excess mortality and morbidity difficult to predict but may be high (but it
doesn’t follow that the next pandemic will be like 1918)
• overall population clinical attack rate is likely to be 25-33%
• there may be a shift towards younger age groups in terms of severity and
mortality – with implications for business workforce
QuickTime™ and a
TIFF (Uncompressed) decompressorare needed to see this picture.
Section 2 – How will the UK medicines supply chain cope?
Context
• In normal times we can experience shortages
• Pandemic Flu may be global sustained threat
• Most production is overseas
QuickTime™ and a
TIFF (Uncompressed) decompressorare needed to see this picture.
DH - mitigating actions so far
• National Pandemic Planning including
– Antivirals – Stockpiles currently being increased to cover 50% of
population
– Antibiotics – Stockpile being created of 14.8 million courses
– Possible Amendments to Medicines Legislation Consultation – response
just published and next step agreed
• Exercise Chain Reaction (ECR) commissioned and held (facilitated
by HPA and MICE Associates)
QuickTime™ and a
TIFF (Uncompressed) decompressorare needed to see this picture.
ECR Background
• Exercise Chain Reaction (ECR) – held 30th January 2008
• Looked at effect of pandemic influenza on community pharmacy supply
chain
• Wide and high level representation from manufacturers, distributors,
community pharmacy and dispensing doctors, associated pharmacy
services and Government departments.
• Sessions on prescription sizes, panic buying, fuel supply difficulties, staff
shortages
• Report on ECR from Health Protection Agency
QuickTime™ and a
TIFF (Uncompressed) decompressorare needed to see this picture.
1st HPA inject re panic buying
• Play HPA DVD Bulletin 2 – re panic buying
QuickTime™ and a
TIFF (Uncompressed) decompressorare needed to see this picture.
ECR players concluded
• Immediate shortage likely and concern relating to impact
on price
• Different mitigating options need to be considered
• Increase stocks – either nationally or encourage
individuals to create their own buffers at home?
QuickTime™ and a
TIFF (Uncompressed) decompressorare needed to see this picture.
2nd HPA inject re staff absence
• Play HPA DVD – Bulletin 4 – re staff absences
QuickTime™ and a
TIFF (Uncompressed) decompressorare needed to see this picture.
ECR players concluded
• Need for Business Continuity Planning• Identify key staff• Need for training and multiskilling• Identify key tasks• Need for remote working• IT infrastructure
QuickTime™ and a
TIFF (Uncompressed) decompressorare needed to see this picture.
Issues raised by ECR players (1)
• Need to maintain normality: - manufacture, distribution, supply and
prescribing
• Likely to be increase in demand for some medicines which could lead to
shortages
• Some current production on two year cycles
• Request for central co-ordination to support planning for priority products
• What if country with manufacturing HQ promotes restrictive practice?
QuickTime™ and a
TIFF (Uncompressed) decompressorare needed to see this picture.
Issues raised by ECR players (2)
• Distribution – Fuel and security issues + possible need for joint
distribution arrangements to ensure all pharmacies covered?
• Would DH request comprehensive review of legal and regulatory
frameworks and establish emergency triggers to allow flexibility?
• Need to understand impact of trigger points in other countries
QuickTime™ and a
TIFF (Uncompressed) decompressorare needed to see this picture.
Issues raised by ECR players (3)
• Supply and prescribing – need to keep to normal
patterns (one month preferable) to support stable supply
chain
• Need for guidance for professionals and public on what
to expect and how to act to mitigate possibility of
shortages.
QuickTime™ and a
TIFF (Uncompressed) decompressorare needed to see this picture.
Summary - Section 3The key strategic measures that will affect
the whole supply chain?• ECR Report being reviewed by DH
• DH legislative amendments – Summary of responses to initial
consultation published and next steps technical consultation to take place
over the summer, led by MHRA
• DH Pandemic Influenza National Framework and supporting guidance
• Business Continuity Plans – Are public organisations DH/SHAs/PCTs and
private companies sharing their plans and co-ordinating action and
resilience?